-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KY703W/izt+sDyyIa1NUugsPQIddv5V9WIxsNg5k4papNg9xWvbci752aXqjVmn6 REi2iaTWOYkCDXp6VzFkJw== 0001179110-05-004531.txt : 20050302 0001179110-05-004531.hdr.sgml : 20050302 20050302123043 ACCESSION NUMBER: 0001179110-05-004531 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041229 FILED AS OF DATE: 20050302 DATE AS OF CHANGE: 20050302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TAPESTRY PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000891504 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 841187753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4840 PEARL EAST CIRCLE STREET 2: SUITE 300W CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-516-8500 MAIL ADDRESS: STREET 1: 4840 PEARL EAST CIRCLE STREET 2: SUITE 300W CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: NAPRO BIOTHERAPEUTICS INC DATE OF NAME CHANGE: 19940421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FIEDLER BRUCE W CENTRAL INDEX KEY: 0001271806 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24320 FILM NUMBER: 05653093 BUSINESS ADDRESS: STREET 1: 4840 PEARL EAST CIRCLE STREET 2: SUITE 300W CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-516-8500 MAIL ADDRESS: STREET 1: C/O TAPESTRY PHARMACEUTICALS, INC STREET 2: 4840 PEARL EAST CIRCLE SUITE 300W CITY: BOULDER STATE: CO ZIP: 80301 5 1 edgar.xml FORM 5 - X0202 5 2004-12-29 0 0 0 0000891504 TAPESTRY PHARMACEUTICALS, INC TPPH 0001271806 FIEDLER BRUCE W 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 0 1 0 0 Controller Common Stock (right to buy) 2.33 2004-04-19 5 A 0 3000 0 A 2014-04-19 Common Stock 3000 3000 D Grant to Reporting Person of a non-statutory stock option under the Issuer's 1994 Long Term Performance Incentive Plan. The option vests at a rate of 25% per year and will be fully vested on the fourth anniversary of the grant date. The option expires 10 years after the grant date, unless it expires sooner pursuant to the terms of the Plan. Kai P. Larson, as Attorney-in-Fact under Power of Attorney given by Reporting Person 2005-03-02 EX-24 2 bwf-poa.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Kai P. Larson, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of NaPro BioTherapeutics, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of December, 2003. /s/ Bruce W. Fiedler -----END PRIVACY-ENHANCED MESSAGE-----